CMS Proposes Extra Payments On CustomFlex Iris, Single-Use Duodenoscope, Heart Device
Medicare agency discusses unique nature of devices in outpatient payment system proposed rule
The Centers for Medicare and Medicaid Services highlighted three FDA breakthrough devices it is proposing for additional pass-through payments in its 2021 outpatient pay rule.
You may also be interested in...
VEO Ophthalmics’ Artificial Iris, Boston Scientific’s Single-Use Duodenoscope Win Pass-Through Payments
US CMS described several products winning device pass-through payment status for 2021 in an outpatient prospective payment system final rule.
Azalea Vision Formed To Develop Artificial Iris
Researchers have created the "smart contact lens" to dynamically improve the vision of people with various optical defects.
‘Right Product, Right Time:’ FDA Clears Boston Scientific's Single-Use Duodenoscope
Amid concerns of infections from duodenoscopes that are not sufficiently re-sterilized, the US FDA has cleared Boston Scientific’s Exalt-D as a the first single-use duodenoscope. Investors expect the device will likely take a significant chunk of the market, especially considering the next competitor is at least a year away.